scholarly article | Q13442814 |
review article | Q7318358 |
P50 | author | Eva Reali | Q58810983 |
P2093 | author name string | Giuseppe Banfi | |
Paolo D Pigatto | |||
Marco Diani | |||
P2860 | cites work | Neuroimmunology: What Role for Autoimmunity, Neuroinflammation, and Small Fiber Neuropathy in Fibromyalgia, Chronic Fatigue Syndrome, and Adverse Events after Human Papillomavirus Vaccination? | Q90851737 |
Stress-Induced Metabolic Disorder in Peripheral CD4+ T Cells Leads to Anxiety-like Behavior | Q91056711 | ||
Silicone breast implants and depression, fibromyalgia and chronic fatigue syndrome in a rheumatology clinic population | Q91300128 | ||
T helper 1 response is correlated with widespread pain, fatigue, sleeping disorders and the quality of life in patients with fibromyalgia and is modulated by hyperbaric oxygen therapy | Q91475555 | ||
Depression, Antidepressants, and Inflammatory Bowel Disease: Implications for Future Models of Care | Q91606824 | ||
Cutaneous TRPV1+ Neurons Trigger Protective Innate Type 17 Anticipatory Immunity | Q92230267 | ||
Mast Cells, Neuroinflammation and Pain in Fibromyalgia Syndrome | Q92711498 | ||
Machine Learning to Understand the Immune-Inflammatory Pathways in Fibromyalgia | Q93016940 | ||
Animal models of anxiety disorders and stress | Q27015028 | ||
How stress influences the immune response | Q28156366 | ||
Human T cells express a functional ionotropic glutamate receptor GluR3, and glutamate by itself triggers integrin-mediated adhesion to laminin and fibronectin and chemotactic migration | Q28189515 | ||
Stress enhances muscle nociceptor activity in the rat | Q28388747 | ||
Mucosal-associated invariant T cell is a potential marker to distinguish fibromyalgia syndrome from arthritis | Q28545955 | ||
Functional expression of corticotropin-releasing hormone (CRH) receptor 1 in cultured rat microglia | Q28567435 | ||
IFN regulatory factor-1 negatively regulates CD4+ CD25+ regulatory T cell differentiation by repressing Foxp3 expression | Q28593964 | ||
The many roles of chemokines and chemokine receptors in inflammation | Q29618880 | ||
Multifaceted interactions between adaptive immunity and the central nervous system | Q30276094 | ||
Unexpected role of interferon-γ in regulating neuronal connectivity and social behaviour. | Q30354422 | ||
Immune status influences fear and anxiety responses in mice after acute stress exposure | Q30412919 | ||
Animal models of anxiety disorders in rats and mice: some conceptual issues | Q30471279 | ||
Concentration of cytokines in patients with osteoarthritis of the knee and fibromyalgia | Q33769464 | ||
Preliminary Evidence of Increased Pain and Elevated Cytokines in Fibromyalgia Patients with Defective Growth Hormone Response to Exercise | Q33844288 | ||
Enhancing versus Suppressive Effects of Stress on Immune Function: Implications for Immunoprotection versus Immunopathology | Q33848598 | ||
Phenotypic Identification of Spinal Cord-Infiltrating CD4(+) T Lymphocytes in a Murine Model of Neuropathic Pain | Q34060424 | ||
Systematic review with meta-analysis: cytokines in fibromyalgia syndrome. | Q34060700 | ||
Mast cells: versatile gatekeepers of pain | Q34225889 | ||
Fibromyalgia and cytokines | Q34400019 | ||
Fibromyalgia: a clinical review | Q34415411 | ||
Prostaglandin E2-induced inflammation: Relevance of prostaglandin E receptors | Q34429724 | ||
The effect of stress on the defense systems | Q34481157 | ||
Fibromyalgia: anti-inflammatory and stress responses after acute moderate exercise | Q34984715 | ||
Role for monocyte chemoattractant protein-1 in the induction of chronic muscle pain in the rat | Q35001326 | ||
Dissociation between sickness behavior and emotionality during lipopolysaccharide challenge in lymphocyte deficient Rag2(-/-) mice | Q35205617 | ||
Fibromyalgia is characterized by altered frontal and cerebellar structural covariance brain networks | Q35232300 | ||
Microglia: scapegoat, saboteur, or something else? | Q35606301 | ||
Macrophage-T cell interactions mediate neuropathic pain through the glucocorticoid-induced tumor necrosis factor ligand system | Q35608087 | ||
Fibromyalgia syndrome in need of effective treatments | Q36186172 | ||
Chemokines, chemokine receptors and pain | Q36229171 | ||
Spinal interleukin-17 promotes thermal hyperalgesia and NMDA NR1 phosphorylation in an inflammatory pain rat model. | Q36584981 | ||
Neuropeptides CRH, SP, HK-1, and Inflammatory Cytokines IL-6 and TNF Are Increased in Serum of Patients with Fibromyalgia Syndrome, Implicating Mast Cells | Q36618726 | ||
Different immune cells mediate mechanical pain hypersensitivity in male and female mice. | Q36633603 | ||
Inflammatory T helper 17 cells promote depression-like behavior in mice | Q36640233 | ||
Cerebrospinal fluid corticotropin-releasing factor concentration is associated with pain but not fatigue symptoms in patients with fibromyalgia | Q36796597 | ||
Prolonged gabapentin analgesia in an experimental mouse model of fibromyalgia | Q36999588 | ||
Animal models of anxiety in mice | Q37012097 | ||
Etiology of fibromyalgia: the possible role of infection and vaccination | Q37244861 | ||
Allergological and toxicological aspects in a multiple chemical sensitivity cohort | Q37400456 | ||
A famciclovir + celecoxib combination treatment is safe and efficacious in the treatment of fibromyalgia | Q37669773 | ||
Evidence of both systemic inflammation and neuroinflammation in fibromyalgia patients, as assessed by a multiplex protein panel applied to the cerebrospinal fluid and to plasma | Q37691644 | ||
Rheumatic manifestations of autoimmune thyroid disease: the other autoimmune disease. | Q38002839 | ||
A focus on mast cells and pain | Q38152516 | ||
Nonneuronal central mechanisms of pain: glia and immune response | Q38368343 | ||
Cannabinoids and autoimmune diseases: A systematic review | Q38733284 | ||
Neuroinflammation as modifier of genetically caused neurological disorders of the central nervous system: Understanding pathogenesis and chances for treatment. | Q38751654 | ||
Medical cannabis: Another piece in the mosaic of autoimmunity? | Q39012168 | ||
Involvement of mast cells in a mouse model of postoperative pain | Q39257584 | ||
Lymphocyte subsets and the role of TH1/TH2 balance in stressed chronic pain patients | Q40128467 | ||
The Lifespan and Turnover of Microglia in the Human Brain | Q41217922 | ||
[EXPRESS] Immune System Involvement in Specific Pain Conditions | Q41381299 | ||
Role of Interferon Regulatory Factor 1 in Governing Treg Depletion, Th1 Polarization, Inflammasome Activation and Antitumor Efficacy of Cyclophosphamide. | Q41991396 | ||
CD4⁺ but not CD8⁺ T cells revert the impaired emotional behavior of immunocompromised RAG-1-deficient mice | Q43063576 | ||
Abnormal overexpression of mastocytes in skin biopsies of fibromyalgia patients | Q43080831 | ||
Stress-induced immune dysfunction: implications for health | Q43472077 | ||
The role of interleukin (IL)-17 in anxiety and depression of patients with rheumatoid arthritis | Q43757311 | ||
IRF-1 deficiency skews the differentiation of dendritic cells toward plasmacytoid and tolerogenic features. | Q43871949 | ||
Chronic urticaria is usually associated with fibromyalgia syndrome | Q44445713 | ||
Posttraumatic stress disorder and physical illness: results from clinical and epidemiologic studies | Q44751614 | ||
HLA antigens in primary fibromyalgia syndrome | Q45255241 | ||
Metal-induced inflammation triggers fibromyalgia in metal-allergic patients. | Q45909285 | ||
Chronic restraint stress induces mechanical and cold allodynia, and enhances inflammatory pain in rat: Relevance to human stress-associated painful pathologies. | Q45926075 | ||
Increased levels of IL-17A in patients with fibromyalgia | Q46112669 | ||
May genetic factors in fibromyalgia help to identify patients with differentially altered frequencies of immune cells? | Q46225786 | ||
High plasma levels of MCP-1 and eotaxin provide evidence for an immunological basis of fibromyalgia | Q46555325 | ||
Mitochondrial dynamics controls anti-tumour innate immunity by regulating CHIP-IRF1 axis stability. | Q47114801 | ||
Metabolic shift induced by systemic activation of T cells in PD-1-deficient mice perturbs brain monoamines and emotional behavior | Q47289459 | ||
Th17 cells in depression. | Q47805738 | ||
CD3+CD56+natural killer T cells in fibromyalgia syndrome patients: association with the intensity of depression | Q48489962 | ||
Visceral pain as a triggering factor for fibromyalgia symptoms in comorbid patients | Q48729925 | ||
Suppression of Brain Mast Cells Degranulation Inhibits Microglial Activation and Central Nervous System Inflammation | Q48956990 | ||
Delayed-type hypersensitivity to metals in connective tissue diseases and fibromyalgia | Q49817489 | ||
Cytokine patterns in fibromyalgia and their correlation with clinical manifestations. | Q50898803 | ||
Induction of Microglial Activation by Mediators Released from Mast Cells. | Q51389324 | ||
Immune markers in fibromyalgia: comparison with major depressed patients and normal volunteers. | Q51996133 | ||
An Inflammation-Centric View of Neurological Disease: Beyond the Neuron. | Q52331711 | ||
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - Evidence for an autoimmune disease. | Q52805572 | ||
Metals as a common trigger of inflammation resulting in non-specific symptoms: diagnosis and treatment. | Q53327036 | ||
Potential Mechanisms Underlying Centralized Pain and Emerging Therapeutic Interventions. | Q53445626 | ||
Serum Monocyte Chemotactic Protein-1 Concentrations Distinguish Patients With Ankylosing Spondylitis From Patients With Mechanical Low Back Pain | Q58620294 | ||
Fibromyalgia diagnosis and biased assessment: Sex, prevalence and bias | Q58744287 | ||
Sequential alteration of microglia and astrocytes in the rat thalamus following spinal nerve ligation | Q60944208 | ||
Altered interleukin-2 secretion in patients with primary fibromyalgia syndrome | Q68305579 | ||
Lymphocyte subpopulations in patients with primary fibromyalgia | Q72576113 | ||
[Absence of correlation between HLA antigens and fibromyalgia syndrome in Italian patients] | Q72638248 | ||
Environmental immunogens and T-cell-mediated responses in fibromyalgia: evidence for immune dysregulation and determinants of granuloma formation | Q72992241 | ||
Lymphocyte markers and natural killer cell activity in fibromyalgia syndrome: effects of low-dose, sublingual use of human interferon-alpha | Q78222526 | ||
Evidence of central inflammation in fibromyalgia-increased cerebrospinal fluid interleukin-8 levels | Q82729060 | ||
Inflammatory/stress feedback dysregulation in women with fibromyalgia | Q84984031 | ||
Altered profile of chemokines in fibromyalgia patients | Q86494070 | ||
Evidence for the modulation of nociception in mice by central mast cells | Q88552824 | ||
Long-term pain, neuroinflammation and glial activation | Q89140185 | ||
Neuroinflammatory mechanisms in amyotrophic lateral sclerosis pathogenesis | Q90496919 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 4 | |
P921 | main subject | fibromyalgia | Q540571 |
P577 | publication date | 2020-02-11 | |
P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
P1476 | title | T Cell Subpopulations in the Physiopathology of Fibromyalgia: Evidence and Perspectives | |
P478 | volume | 21 |
Search more.